Potential epigenetic modifications implicated in triple- to quadruple-negative breast cancer transition: a review.
Muhammad AliyuGilead Ebiegberi ForcadosBabangida Sanusi KatsayalRabiatu Suleiman BakoSuleiman AminuIdris Zubairu SadiqMurtala Bello AbubakarAbdurrahman Pharmacy YusufIbrahim MalamiMohammed FarukSani IbrahimPeter Abur PaseSaad A AhmedIbrahim Babangida AbubakarMurtala AbubakarClayton C YatesPublished in: Epigenomics (2022)
Current research on triple-negative breast cancer (TNBC) has resulted in delineation into the quadruple-negative breast cancer (QNBC) subgroup. Epigenetic modifications such as DNA methylation, histone posttranslational modifications and associated changes in chromatin architecture have been implicated in breast cancer pathogenesis. Herein, the authors highlight genes with observed epigenetic modifications that are associated with more aggressive TNBC/QNBC pathogenesis and possible interventions. Advanced literature searches were done on PubMed/MEDLINE, Scopus and Google Scholar. The results suggest that nine epigenetically altered genes/differentially expressed proteins in addition to the downregulated androgen receptor are associated with TNBC aggressiveness and could be implicated in the TNBC to QNBC transition. Thus, restoring the normal expression of these genes via epigenetic reprogramming could be therapeutically beneficial to TNBC and QNBC patients.
Keyphrases
- dna methylation
- genome wide
- gene expression
- helicobacter pylori
- copy number
- end stage renal disease
- helicobacter pylori infection
- ejection fraction
- chronic kidney disease
- poor prognosis
- systematic review
- bioinformatics analysis
- prognostic factors
- risk assessment
- clinical trial
- oxidative stress
- transcription factor
- genome wide identification
- physical activity
- peritoneal dialysis
- long non coding rna
- human health
- binding protein
- genome wide analysis
- open label